We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$4.42B
AUM Growth
+$200M
(+4.7%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
20.05%
Holding
1,701
New
123
Increased
762
Reduced
644
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$34.6M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$24.7M |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$22.5M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$15.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.4M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$15.2M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$10.9M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$10.6M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.64% |
| 2 | Technology | 4.52% |
| 3 | Healthcare | 4.42% |
| 4 | Consumer Staples | 4.24% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
iShares Expanded Tech-Software Sector ETF
IGV
$15.2B
| $778K | 0.02% |
38,630
-855
| -2% | -$16.2K |
|
677
Guggenheim Strategic Opportunities Fund
GOF
$2.39B
| $777K | 0.02% |
45,742
-1,307
| -3% | -$21.1K |
|
678
Adobe
ADBE
$108B
| $774K | 0.02% |
8,255
+856
| +12% | +$74.2K |
|
679
Invesco Zacks Multi-Asset Income ETF
CVY
$125M
| $774K | 0.02% |
41,885
+5,468
| +15% | +$96K |
|
|
NIO
680
DELISTED
NUVEEN MUNICIPAL OPPORTUNITY FUND INC
NIO
| $773K | 0.02% |
52,481
+7,140
| +16% | +$104K |
|
681
Schwab US TIPS ETF
SCHP
$16.2B
| $772K | 0.02% |
27,800
+9,144
| +49% | +$247K |
|
682
NXP Semiconductors
NXPI
$58.5B
| $768K | 0.02% |
9,477
+615
| +7% | +$45.9K |
|
683
Regeneron Pharmaceuticals
REGN
$83.1B
| $767K | 0.02% |
2,127
-87
| -4% | -$35.9K |
|
684
Fidelity MSCI Industrials Index ETF
FIDU
$2.39B
| $765K | 0.02% |
26,935
-44,100
| -62% | -$1.16M |
|
685
iShares MSCI Germany ETF
EWG
$1.67B
| $757K | 0.02% |
29,423
+21,193
| +258% | +$516K |
|
|
FTR
686
DELISTED
Frontier Communications Corp.
FTR
| $756K | 0.02% |
9,015
+702
| +8% | +$51K |
|
|
DHC
687
Diversified Healthcare Trust
DHC
$2.02B
| $754K | 0.02% |
42,167
-86
| -0.2% | -$1.34K |
|
688
Vanguard Total World Stock ETF
VT
$81.8B
| $753K | 0.02% |
13,054
-6,881
| -35% | -$375K |
|
|
POT
689
DELISTED
Potash Corp Of Saskatchewan
POT
| $752K | 0.02% |
44,207
+7,086
| +19% | +$119K |
|
690
AB InBev
BUD
$158B
| $750K | 0.02% |
6,015
+83
| +1% | +$9.85K |
|
|
FSD
691
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
| $750K | 0.02% |
51,280
+518
| +1% | +$7.2K |
|
692
Compass Minerals
CMP
$1.11B
| $748K | 0.02% |
10,560
+3,864
| +58% | +$276K |
|
693
VF Corp
VFC
$5.79B
| $748K | 0.02% |
12,263
-2,342
| -16% | -$136K |
|
694
Kohl's
KSS
$2.22B
| $747K | 0.02% |
16,020
+7,940
| +98% | +$373K |
|
695
Sanofi
SNY
$105B
| $745K | 0.02% |
18,552
-3,670
| -17% | -$147K |
|
696
Middleby
MIDD
$5.31B
| $744K | 0.02% |
6,964
-1,854
| -21% | -$174K |
|
697
ASE Group
ASX
$103B
| $743K | 0.02% |
127,042
-1,978
| -2% | -$10.8K |
|
698
Lazard
LAZ
$4.42B
| $741K | 0.02% |
19,107
+1,054
| +6% | +$37.8K |
|
699
Marriott International
MAR
$91.9B
| $740K | 0.02% |
10,403
+2,582
| +33% | +$169K |
|
700
Hawaiian Electric Industries
HE
$2.05B
| $739K | 0.02% |
22,802
-642
| -3% | -$19.2K |
|
Similar funds
LP
HF
Cambridge Investment Research Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Cambridge Investment Research Advisors held 1,701 positions worth $4.42B, up 4.7% from $4.22B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $138M of net new capital in Q1 2016, opening 123 new positions and adding to 762 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.4M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2016 buy was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
- Cambridge Investment Research Advisors added most to DIPLOMAT PHARMACY, INC. in Q1 2016, an estimated $34.6M increase.
- Cambridge Investment Research Advisors's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.4M.
- Cambridge Investment Research Advisors fully exited iShares Currency Hedged MSCI Emerging Markets in Q1 2016, selling an estimated $1.72M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $4.42B portfolio in Q1 2016.
- Cambridge Investment Research Advisors opened 123 new positions and closed 96 in Q1 2016.
- Cambridge Investment Research Advisors's portfolio value rose 4.7% quarter-over-quarter to $4.42B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.